Research Paper Volume 12, Issue 18 pp 18676—18692
Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
Figure 5. Validation of the prognosis of MMP14 and PKM2 in three GEO datasets. (A) Kaplan-Meier survival analysis was used to compare the overall survival of MMP14 highly expressed patients (red) with MMP14 lowly expressed patients (black) in GSE21250, GSE28735 and GSE57495 datasets. P values were generated from Log-rank test. (B) Kaplan-Meier survival analysis was used to compare the overall survival of PKM2 highly expressed patients (red) with PKM2 lowly expressed patients (black) in GSE21250, GSE28735 and GSE57495 datasets.